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Abstract Polymyxin acts as an ultimate line of refuge
against the severe infections by multidrug-resistant Gram-
negative pathogens. This conventional idea is challenged
dramatically by the recent discovery of mobile colistin
resistance gene (mcr-1) is prevalent in food animals and
human beings worldwide. More importantly, the mcr-1
gene was found to be co-localized with other antibiotic
resistance genes, raising the possibility that super-bugs
with pan-drug resistance are emerging. However, little is
reported on the genomes of the mcr-1-positive bacterial
host reservoirs. Here we report genome sequencing of three
human isolates of the mcr-1-positive Escherichia coli
(E15004, E15015 and E15017) and define general features
through analyses of bacterial comparative genomics. Fur-
ther genomic mining together with sequence typing
allowed us to elucidate that the MCR-1-carrying E. coli
E15017 belongs to the sequence type ST648 and copro-
duces extended-spectrum b-lactamase (ESBL). Given the
fact that ST648 has been known to associate with either
New Delhi metallo-b-lactamase 1 or ESBL, our results
highlighted the possibility of ST648 as an epidemic clone
with multidrug resistances.
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The identification of the mobilized colistin resistance gene
mcr-1 recently attracted extensive attention from the sci-
entific community. MCR-1 confers resistance to
polymyxins, a group of polypeptide antibiotics that are
currently considered the last refuge of therapeutics against
lethal challenges by Gram-negative pathogens with multi-
drug resistance [1, 2]. Very recently, two separate groups
reported the co-occurrence of MCR-1 and extended-spec-
trum b-lactamase (ESBL) on plasmids in Enterobacteri-
aceae [3–6]. However, genomic hallmarks of the bacterial
host reservoir for the mcr-1-harbouring plasmids remain
unclear. Here we report on their genomic compositions.
After three mcr-1-positive E. coli isolates (E15004,
E15015 and E15017) were successfully screened from the
microbiota of clinical diarrhea patients [7], we applied
next-generation Illumina MiSeq sequencing to decode their
genomic sequences. The pool of paired-end reads produced
here were assembled with GS De Novo Assembler into a
collection of contigs. Then the individual contigs were
ordered into draft genomes with the prototypical strain of
E. coli MG1655 as the reference (Fig. 1, S1). Relative to
the paradigm version of E. coli, MG1655 (4,641,425 bp),
the three mcr-1-positive clinical E. coli isolates exhibited
variations in the size of sequenced genomes (i.e.,
4,643,275 bp for strain E15004; 4,637,424 bp for strain
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E15015, and 4,780,540 bp for strain E15017) (Table S1).
The values of their GC percentages are all approximately
50 % (Table S1), although the draft genomes identified
several regions with a strong GC skew, indicative of novel
insertions of genomic material.
Further comparative genomics suggests that genetic
heterogeneity is present in the three mcr-1-positive E. coli
isolates (Fig. 1, S2). We retrieved the sequences of seven
house-keeping genes (adk, fumC, gyrB, icd, mdh, purA and
recA) from the above three sequenced genomes and sub-
jected them to analyses of Multi-Locus Sequence Typing
(MLST) (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). Unlike
the epidemic spreading clone, E. coli ST131 that carried
the mcr-1 gene in Denmark [8], the three mcr-1-harbouring
clinical strains belong to different sequence types (i.e.,
E15004 is in ST40, E15015 is in ST642, and E15017 is in
ST648) (Table 1, Fig. S3), which is generally consistent
with our findings from comparative genomics (Fig. 1, S2).
The fact that mcr-1-harbouring E. coli isolates are classi-
fied into different sequence types argues that the dissemi-
nation of mcr-1 colistin resistance gene is ongoing by
clonal expansion [9]. Given the fact that E. coli ST648 was
associated with ESBL [10, 11] and two variants of New
Delhi metallo-b-lactamase 1 (NDM-1), NDM-5 [12] and
NDM-7 [13]), we thereby were interested in determining
whether or not the genes of ESBL and NDM would also be
found with the mcr-1 gene in the ST648 strain, E15017.
Using ResFinder2.1, a newly-improved database for
identifying antibiotic resistance genes (https://cge.cbs.dtu.
dk/services/ResFinder), we screened the above three
genomic sequences, as well as the remaining unordered
contigs, which likely encode additional plasmids, for the
Fig. 1 Genomics-based discovery of multidrug-resistant genes in the mcr-1-positive ST648 E. coli coproducing extended-spectrum b-
lactamase. Circular comparison of the three sequenced genomes (E15004, E15015 and E15017) with the paradigm strain MG1655 as the
reference. Individual rings range from 1 (inner ring) to 4 (outer ring). (Ring 1—red) Strain 15005 conservation plot. (Ring 2—green) Strain
15015 conservation plot. (Ring 3—blue) Strain 15015 conservation plot. (Ring 4—magenta/green) GC Skew of MG1655 reference genome
[(G-C)/(G?C)] magenta[ 0, green\ 0
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presence of antibiotic resistance genes esp. ESBL and
NDM-1 (and/or its variants). As anticipated, a 100 %
identical mcr-1 gene was observed in the unordered contigs
in each of the three strains. NDM-1 variants were not
found, which we then verified by PCR-based detection (not
shown). Unexpectedly, no other antibiotic resistance gene
besides mcr-1 is found in the strain E15004 (ST40) (not
shown), whereas multiple drug-resistance genes apart from
mcr-1 were identified in the unordered contigs from the
other two strains, E15015 (ST642) and E15017 (ST648)
(Table 2, S2). In particular, the blaCTX-M-15 gene that
encodes ESBL was found to be present in the ST648 strain,
E15017 (Table 2). Additionally, we noted that the mcr-1
and blaCTX-M-15 are located inside distinct unordered
contigs, suggesting the possibility that they are encoded on
different plasmids. This represents the first example of a
clinical clone of E. coli with a sequence type of ST648 that
has the potential to spread MCR-1 colistin resistance
together with ESBL resistance.
In summary, our data provides genomic insights into
three strains of mcr-1-positive E. coli with multiple drug
resistance, which reveals the increasing possibility of
ST648 becoming an epidemic vector for circulation/spread
of the mcr-1 colistin resistance gene in China. As the inter/
intra-species dissemination of the mcr-1 gene has been
linked to the spread of other drug resistance including
ESBL [11] and NDM-1 variants [12, 13], our findings
underscore the urgent need to modulate and control the use
of colistin in veterinary/clinical practices, which might
facilitate prevention of the further emergence of superbugs
with multi-drug resistance.
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